Open access · CC-BY
via OpenAlex
Clinical biomarker-based biological aging and risk of cancer in the UK Biobank
Jonathan K. L. Mak, Christopher E McMurran, Ralf Kuja‐Halkola, Per Hall, Kamila Czene, Juulia Jylhävä, Sara Hägg
British Journal of Cancer · 2023 · ▲ 153 citations
Abstract
BACKGROUND: Despite a clear link between aging and cancer, there has been inconclusive evidence on how biological age (BA) may be associated with cancer incidence. METHODS: We studied 308,156 UK Biobank participants with no history of cancer at enrolment. Using 18 age-associated clinical biomarkers, we computed three BA measures (Klemera-Doubal method [KDM], PhenoAge, homeostatic dysregulation [HD]) and assessed their associations with incidence of any cancer and five common cancers (breast, prostate, lung, colorectal, and melanoma) using Cox proportional-hazards models. RESULTS: A total of 35,426 incident cancers were documented during a median follow-up of 10.9 years. Adjusting for common cancer risk factors, 1-standard deviation (SD) increment in the age-adjusted KDM (hazard ratio = 1.04, 95% confidence interval = 1.03-1.05), age-adjusted PhenoAge (1.09, 1.07-1.10), and HD (1.02, 1.01-1.03) was significantly associated with a higher risk of any cancer. All BA measures were also associated with increased risks of lung and colorectal cancers, but only PhenoAge was associated with breast cancer risk. Furthermore, we observed an inverse association between BA measures and prostate cancer, although it was attenuated after removing glycated hemoglobin and serum glucose from the BA algorithms. CONCLUSIONS: Advanced BA quantified by clinical biomarkers is associated with increased risks of any cancer, lung cancer, and colorectal cancer.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41416-023-02288-w
- Canonical
- link ↗
- Fetched
- 2026-07-25 MST
Cite this
APA
Mak, J.K.L., McMurran, C.E., Kuja‐Halkola, R., Hall, P., Czene, K., Jylhävä, J., & Hägg, S. (2023). Clinical biomarker-based biological aging and risk of cancer in the UK Biobank. <em>British Journal of Cancer</em>. https://doi.org/10.1038/s41416-023-02288-w
Vancouver
Mak JKL, McMurran CE, Kuja‐Halkola R, Hall P, Czene K, Jylhävä J, et al. Clinical biomarker-based biological aging and risk of cancer in the UK Biobank. British Journal of Cancer. 2023. doi:10.1038/s41416-023-02288-w.
BibTeX
@article{jonathan2023Clinic,
title = {Clinical biomarker-based biological aging and risk of cancer in the UK Biobank},
author = {Jonathan K. L. Mak and Christopher E McMurran and Ralf Kuja‐Halkola and Per Hall and Kamila Czene and Juulia Jylhävä and Sara Hägg},
journal = {British Journal of Cancer},
year = {2023},
doi = {10.1038/s41416-023-02288-w},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
medRxiv 2023
Preprint · OA
Aging measures and cancer: Findings from the Health and Retirement Study
International Journal of Cancer 2017
Open access · OA
DNA methylation‐based biological aging and cancer risk and survival: Pooled analysis of seven prospective studies
JACC Asia 2026
Open access · CC-BY
Biological Age Acceleration and All-Cause Mortality in Moderate to Severe Aortic Valve Stenosis
Digestive Diseases and Sciences 2025
Open access · CC-BY
Evaluating Risk Factors for Early-Onset Colorectal Cancer in a Large, Prospective Cohort
Scientific Reports 2025
Open access · CC-BY
Associations of biological aging with the morbidity and all-cause mortality of patients with lung cancer
Clinical Epigenetics 2021
Open access · CC-BY